| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 12/11/2001 | US6328971 MAGE-1 derived nona peptides, and compositions thereof |
| 12/11/2001 | US6328969 Method and compositions for stimulation of an immune response to a differentiation antigen stimulated by an altered differentiation antigen |
| 12/11/2001 | US6328968 Organ transplant |
| 12/11/2001 | US6328967 Delivery system to modulate immune response |
| 12/11/2001 | US6328965 Vaccine adjuvants |
| 12/11/2001 | US6328964 Method to treat multiple sclerosis with GP39-specific antibodies |
| 12/11/2001 | US6328963 For purifying or assaying human mp52 produced b genetic engineering techniques |
| 12/11/2001 | US6328962 Conjugate molecules are produced by genetic modification of genes encoding light and heavy chains of the surface structure specific antibody and expression in mammal cells to produce the conjugated antibody; enhanced immune response |
| 12/11/2001 | US6328960 Administering to transplant recipient mesenchymal stem cells in an amount effective to reduce an immune response of effector cells against an alloantigen to effector cells |
| 12/11/2001 | US6328957 Heat shock proteins and the treatment of tumors |
| 12/11/2001 | US6328956 Pharmaceutical composition for the treatment or prevention of a malignant tumor |
| 12/11/2001 | US6328954 Use of the IL-4 receptor for the therapy prophylaxis and diagnosis of allergic viral parasitic and bacterial diseases and of fungal infections |
| 12/11/2001 | CA2329482C Recombinant antibodies specific for tnf-.alpha. |
| 12/11/2001 | CA2162132C Hepatitis b virus mutants, reagents and methods for detection |
| 12/11/2001 | CA2136429C Combined vaccines comprising hepatitis b surface antigen and other antigens |
| 12/11/2001 | CA2117953C Human stromal derived factor 1 alpha and 1 beta and dnas encoding the same |
| 12/11/2001 | CA2066053C Recombinant retroviruses delivering vector constructs to target cells |
| 12/09/2001 | CA2349960A1 Ibdv strain for in ovo administration |
| 12/09/2001 | CA2309379A1 Viral variants and uses therefor |
| 12/06/2001 | WO2001092891A2 Regulating lipid levels via the zmax1 or hbm gene |
| 12/06/2001 | WO2001092876A2 Method for identifying compounds for modulating the activity of a tumour suppressor protein |
| 12/06/2001 | WO2001092581A2 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 12/06/2001 | WO2001092551A2 Duplexed parvovirus vectors |
| 12/06/2001 | WO2001092548A2 Vaccine and gene therapy vector and methods of use thereof |
| 12/06/2001 | WO2001092547A2 Modified bovine adenovirus having altered tropism |
| 12/06/2001 | WO2001092546A1 Production of recombinant allergens in plant cells |
| 12/06/2001 | WO2001092535A1 Bartonella henselae virb operon and proteins encoded thereby |
| 12/06/2001 | WO2001092532A1 Cloning and sequencing of dac g5 allergen of dactylis glomerata pollen, preparation and use thereof |
| 12/06/2001 | WO2001092531A1 Cloning and sequencing the dac g1 allergen of dactylis glomerata pollen, preparation and use thereof |
| 12/06/2001 | WO2001092530A1 Nucleic acid molecule comprising a nucleic acid sequence coding for an sdf-1 gamma chemokine, a neuropeptide precursor or at least one neuropeptide |
| 12/06/2001 | WO2001092528A2 Method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 12/06/2001 | WO2001092525A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 12/06/2001 | WO2001092484A2 Adjuvant preparation for the induction of specific immunity |
| 12/06/2001 | WO2001092474A1 Alpha (2) macroglobulin receptors as a heat shock protein receptor and uses thereof |
| 12/06/2001 | WO2001092470A2 Dna expression vectors and methods of use |
| 12/06/2001 | WO2001092464A2 Therapeutic vaccine preparation and treatment for hiv viral infection |
| 12/06/2001 | WO2001092336A1 Lactoferrin polypeptides from h. pylori and vaccine compositions thereof |
| 12/06/2001 | WO2001092331A2 Compositions and methods for the treatment of immune related diseases |
| 12/06/2001 | WO2001092321A2 Proteins involved in cytoadhesion of plasmodium falciparum ring-stage-infected erythrocytes |
| 12/06/2001 | WO2001092313A2 Methods for isolating and using fungal hemolysins |
| 12/06/2001 | WO2001092307A2 Therapeutic compounds for ovarian cancer |
| 12/06/2001 | WO2001092306A2 Therapeutic compounds for ovarian cancer |
| 12/06/2001 | WO2001092294A2 Therapeutic anti-melanoma compounds |
| 12/06/2001 | WO2001091808A2 Bioconjugates of nanoparticles as radiopharmaceuticals |
| 12/06/2001 | WO2001091803A2 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 12/06/2001 | WO2001091793A1 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders |
| 12/06/2001 | WO2001091792A2 Anti-adhesion molecule antibody to treat inflammation and cancer by inducing the idiotypic network |
| 12/06/2001 | WO2001091790A1 Vaccine composition |
| 12/06/2001 | WO2001091789A2 Combination of a mutant herpes virus and a chemotherapeutic agent for the treatment of cancer |
| 12/06/2001 | WO2001091788A1 Outer membrane vesicle vaccine against disease caused by neisseria meningitidis serogroup a and process for the production thereof |
| 12/06/2001 | WO2001091787A1 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy |
| 12/06/2001 | WO2001091739A2 Compositions and methods for treating neoplastic disease using chemotherapy and radiation sensitizers |
| 12/06/2001 | WO2001091536A2 Genetic vaccine that mimics natural viral infection and induces long-lasting immunity to pathogens |
| 12/06/2001 | WO2001053351A3 Apoptin bindendes protein |
| 12/06/2001 | WO2001052875A8 Vegf-d/vegf-c/vegf peptidomimetic inhibitor |
| 12/06/2001 | WO2001052614A3 Selecting and producing t cell peptide epitopes |
| 12/06/2001 | WO2001047546A3 Methods and products for tumor immunotherapy using cytokines |
| 12/06/2001 | WO2001046392A3 Homologues of human heparanase and splice variants thereof |
| 12/06/2001 | WO2001046225A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 12/06/2001 | WO2001046224A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 12/06/2001 | WO2001039796A3 Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases |
| 12/06/2001 | WO2001034646A3 Recombinant gelatins |
| 12/06/2001 | WO2001032864A3 Gpcr-kd5 polypeptides and dna sequences thereof |
| 12/06/2001 | WO2001030854A3 Antibody to human gastrointestinal epithelial tumor antigen related to alpha 6 beta 4 integrin |
| 12/06/2001 | WO2001030381A3 Use of csf-1 inhibitors |
| 12/06/2001 | WO2001023421B1 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease |
| 12/06/2001 | WO2001022922A3 Engineering antibodies that bind irreversibly |
| 12/06/2001 | WO2001021653A3 Ovarian tumor antigen and methods of use therefor |
| 12/06/2001 | WO2001018042A3 Apoptosis proteins |
| 12/06/2001 | WO2001014416A3 Synthetic papillomavirus genes optimized for expression in human cells |
| 12/06/2001 | WO2001012775A8 25 human secreted proteins |
| 12/06/2001 | WO2000050443A9 Secreted proteins and uses thereof |
| 12/06/2001 | WO2000025804A9 A method for inhibition of phospholamban activity for the treatment of cardiac disease and heart failure |
| 12/06/2001 | WO2000011036A9 AN ANTI-CYANOVIRIN ANTIBODY WITH AN INTERNAL IMAGE OF gp120, A METHOD OF USE THEREOF, AND A METHOD OF USING A CYANOVIRIN TO INDUCE AN IMMUNE RESPONSE TO gp120 |
| 12/06/2001 | WO2000006599A8 Inhibitors of hiv membrane fusion |
| 12/06/2001 | US20010049360 Betaglycan as an inhibin receptor and uses thereof |
| 12/06/2001 | US20010049144 Genetically engineering a primate for expression of a desired gene, comprising introducing into the primate a transgene of a Rous Sarcoma Virus promoter (RSV) and a nucleic acid sequence heterologous to said RSV promoter; gene therapy |
| 12/06/2001 | US20010049142 A rapid, simple-to-use method to differentiate nondividing cells by fusing two different cells and then purifying them without antibiotic or metabolic selection; kits with two nontoxic dyes and instructions; antitumor agents |
| 12/06/2001 | US20010049137 DNA fragments derived from the genomic DNA of HPV-33, including recombinant vectors, which cells are replicated in host cells and expressed as immunogenic proteins; diagnosis of tumors; antibodies to detect viral infections |
| 12/06/2001 | US20010049121 Polypeptides and polynucleotides; drug screening, use in therapy, diagnostic assays |
| 12/06/2001 | US20010049106 ADAM (A Disintegrin And Metalloprotease) family of metalloproteases, and in addition contain thrombospondin domain (TS); treating diabetes, arthritis, cancer, solid tumors, autoimmune diseases |
| 12/06/2001 | US20010048930 Incubation lymphocytes with antigen; complexing |
| 12/06/2001 | US20010048929 Novel multi-oligosaccharide glycoconjugate bacterial meningitis vaccines |
| 12/06/2001 | US20010048927 Porin B (PorB) as a therapeutic target for prevention and treatment of infection by chlamydia |
| 12/06/2001 | US20010048925 Core or carrier adjuvant for vaccine |
| 12/06/2001 | US20010048922 Stimulating immune response to taregted antigen; binding |
| 12/06/2001 | US20010048921 Forming chimeric bone marrow |
| 12/06/2001 | DE10025521A1 Tumor-assoziiertes Antigen B132 Tumor-associated antigen B132 |
| 12/06/2001 | CA2414207A1 Adjuvant preparation for the induction of specific immunity |
| 12/06/2001 | CA2414125A1 Bartonella henselae virb operon and proteins encoded thereby |
| 12/06/2001 | CA2411404A1 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 12/06/2001 | CA2411040A1 Therapeutic anti-melanoma compounds |
| 12/06/2001 | CA2410903A1 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy |
| 12/06/2001 | CA2410895A1 Therapeutic compounds for ovarian cancer |
| 12/06/2001 | CA2410883A1 Methods for isolating and using fungal hemolysins |
| 12/06/2001 | CA2410865A1 Therapeutic compounds for ovarian cancer |
| 12/06/2001 | CA2410736A1 Alpha (2) macroglobulin receptors as a heat shock protein receptor and uses thereof |
| 12/06/2001 | CA2410665A1 Modified bovine adenovirus having altered tropism |
| 12/06/2001 | CA2410652A1 Outer membrane vesicle vaccine against disease caused by neisseria meningitidis serogroup a and process for the production thereof |
| 12/06/2001 | CA2410624A1 Compositions and methods for the therapy and diagnosis of lung cancer |